Marrone Bio Innovations (NASDAQ: MBII)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.020 | -0.040 | -0.0200 | ||||
REV | 12.600M | 11.097M | -1.503M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Marrone Bio Innovations (NASDAQ: MBII) through any online brokerage.
Other companies in Marrone Bio Innovations’s space includes: Mosaic (NYSE:MOS), Corteva (NYSE:CTVA), CF Industries Holdings (NYSE:CF), Intrepid Potash (NYSE:IPI) and China Green Agriculture (NYSE:CGA).
The latest price target for Marrone Bio Innovations (NASDAQ: MBII) was reported by Roth Capital on Wednesday, September 22, 2021. The analyst firm set a price target for 2.00 expecting MBII to rise to within 12 months (a possible 104.71% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Marrone Bio Innovations (NASDAQ: MBII) is $0.977 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Marrone Bio Innovations.
Marrone Bio Innovations’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Marrone Bio Innovations.
Marrone Bio Innovations is in the Materials sector and Chemicals industry. They are listed on the NASDAQ.